Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model

The highly efficacious live-attenuated 17D yellow fever (YF) vaccine is occasionally associated with rare life-threatening adverse events. Modified vaccinia virus Ankara (MVA), a non-replicating poxvirus, has been used as a vaccine platform to safely deliver various antigens. A MVA-based YF vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Julander, Justin G., Testori, Marco, Cheminay, Cédric, Volkmann, Ariane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082969/
https://www.ncbi.nlm.nih.gov/pubmed/30116244
http://dx.doi.org/10.3389/fimmu.2018.01756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082969/
https://www.ncbi.nlm.nih.gov/pubmed/30116244
http://dx.doi.org/10.3389/fimmu.2018.01756

Ejemplares similares